Disease State Primary Cells Bring Verification and Validation Studies Closer to Real-World Results
BIOIVT SPONSORED CONTENT

Disease State Primary Cells Bring Verification and Validation Studies Closer to Real-World Results

Disease State Primary Cells Bring Verification and Validation Studies

The development of manufacturing processes in cell and gene therapy, as well as the testing of ancillary equipment, consumables, media and reagents, have historically been done using starting material from healthy donors. This white paper explores the the question of whether these “normal” cells are the best representation of the real world. Would it be more beneficial to use starting materials that are sourced from patients with diseases? Download this white paper to learn more.

Download Now

    Please fill out the information below to download the content. If you are already registered, or have requested a quote before, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

    • By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.